KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pfizer (PFE) Debt Ratio (2016 - 2026)

Pfizer has reported Debt Ratio over the past 18 years, most recently at 0.31 for Q1 2026.

  • Quarterly Debt Ratio rose 3.79% to 0.31 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 0.31 through Mar 2026, up 3.79% year-over-year, with the annual reading at 0.31 for FY2025, 3.88% up from the prior year.
  • Debt Ratio was 0.31 for Q1 2026 at Pfizer, roughly flat from 0.31 in the prior quarter.
  • Over five years, Debt Ratio peaked at 0.89 in Q4 2022 and troughed at 0.18 in Q4 2022.
  • The 5-year median for Debt Ratio is 0.3 (2024), against an average of 0.31.
  • The largest YoY upside for Debt Ratio was 74.51% in 2023 against a maximum downside of 66.82% in 2023.
  • A 5-year view of Debt Ratio shows it stood at 0.18 in 2022, then skyrocketed by 74.51% to 0.32 in 2023, then fell by 5.59% to 0.3 in 2024, then increased by 3.88% to 0.31 in 2025, then dropped by 0.45% to 0.31 in 2026.
  • Per Business Quant, the three most recent readings for PFE's Debt Ratio are 0.31 (Q1 2026), 0.31 (Q4 2025), and 0.3 (Q3 2025).